colorectal cancer above to 12 cm from the anal verge
unresectable synchronous metastases
no contraindications for chemotherapy
absence of peritoneal carcinomatosis, central nervous system o bone metastasis.
performance status ECOG = 2 (Eastern Cooperative Oncology Group)
uncontrolled concomitant medical conditions that may compromise to chemotherapy
significant symptomatic cardiac disease
not pregnancy or breastfeeding

NCT02015923_inc_T1
Condition
colorectal cancer
NCT02015923_inc_T2
Qualifier
above to 12 cm from the anal verge
NCT02015923_inc_T3
Qualifier
unresectable
NCT02015923_inc_T4
Qualifier
synchronous
NCT02015923_inc_T5
Condition
metastases
NCT02015923_inc_T6
Procedure
chemotherapy
NCT02015923_inc_T7
Condition
contraindications
NCT02015923_inc_T8
Negation
no
NCT02015923_inc_T9
Condition
peritoneal carcinomatosis
NCT02015923_inc_T10
Negation
absence
NCT02015923_inc_T11
Condition
tral nervous system o astasis.
p
NCT02015923_inc_T12
Condition
bone metastasis
NCT02015923_inc_T13
Scope
peritoneal carcinomatosis, central nervous system o bone metastasis
NCT02015923_inc_T14
Measurement
ECOG
NCT02015923_inc_T15
Value
= 2
NCT02015923_inc_T16
Measurement
performance status
NCT02015923_inc_T17
Measurement
Eastern Cooperative Oncology Group
NCT02015923_inc_T18
Scope
ormance status ECOG = 2 ern Cooperative Oncology Group)
un
NCT02015923_inc_T19
Qualifier
uncontrolled
NCT02015923_inc_T20
Temporal
concomitant
NCT02015923_inc_T21
Condition
medical conditions that may compromise to chemotherapy
NCT02015923_inc_T22
Qualifier
symptomatic
NCT02015923_inc_T23
Condition
cardiac disease
NCT02015923_inc_T24
Qualifier
significant
NCT02015923_inc_T25
Condition
pregnancy
NCT02015923_inc_T26
Observation
breastfeeding
NCT02015923_inc_T27
Negation
not
NCT02015923_inc_T28
Scope
pregnancy or breastfeeding